Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Pharmacotherapy of heart failure: Impact of the 2021 guideline update on guideline-directed medical therapy assessed using a Japanese employee health insurance claims database.

The 2021 guideline update was associated with increased use of sacubitril/valsartan and dapagliflozin, resulting in greater overall GDMT intensity, however, these findings are limited to data from 2021, and further long-term studies are needed to evaluate trends in GDMT utilization.

T. Uno, K. Hosomi, S. Yokoyama · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.